N- or C-terminal NanoLuc/Kinase fusions were encoded in pFN31K or pFC32K expression vectors (Promega), including flexible Gly-Ser-Ser-Gly linkers between Nluc and each full-length kinase. Optimal orientations for each construct are described in Table S1 . For cellular BRET target engagement experiments, HEK-293 or HeLa cells were transfected with NLuc/target fusion constructs using FuGENE HD (Promega) according to the manufacturer’s protocol. Briefly, Nluc/target fusion constructs were diluted into Transfection Carrier DNA (Promega) at a mass ratio of 1:10 (mass/mass), after which FuGENE HD was added at a ratio of 1:3 (μg DNA: μL FuGENE HD). 1 part (vol) of FuGENE HD complexes thus formed were combined with 20 parts (vol) of HEK-293 cells suspended at a density of 2 x 105 per mL, followed by incubation in a humidified, 37°C/5% CO2 incubator for 20 hr. For broad kinase profiling experiments, kinase transfections were performed in 96-well plates using plasmid DNAs arrayed based on energy transfer probe affinity. To simplify the work flow, energy transfer probes were binned based on their optimal concentrations for each kinase target. Based on these groupings, the work flow could be simplified and 178 individual kinases could be queried by a single person, in a single day. The analysis can be performed without any automated liquid handling instruments or robotics. Following transfection, cells were washed and resuspended in Opti-MEM. BRET assays were performed in white, 96-well plates (Corning) at a density of 2 x 104 cells/well. All chemical inhibitors were prepared as concentrated stock solutions in DMSO (Sigma-Aldrich) and diluted in Opti-MEM (unless otherwise noted) to prepare working stocks. Cells were equilibrated for 2 hr with energy transfer probes and test compound prior to BRET measurements. Energy transfer probes were prepared at a working concentration of 20X in tracer dilution buffer (12.5 mM HEPES, 31.25% PEG-400, pH 7.5). For target engagement analysis, the energy transfer probes were added to the cells at concentrations optimized for each target, as described in Table S1 . For analysis of DDR1 and DDR2 with compound 6j, energy transfer probe 6 was used at a concentration of 300 nM and 330 nM, respectively. To measure BRET, NanoBRET NanoGlo Substrate and Extracellular NanoLuc Inhibitor (Promega) were added according to the manufacturer’s recommended protocol, and filtered luminescence was measured on a GloMax Discover luminometer equipped with 450 nm BP filter (donor) and 600 nm LP filter (acceptor), using 0.5 s integration time. Milli-BRET units (mBU) are calculated by multiplying the raw BRET values by 1000. Apparent tracer affinity values (EC50) were determined using the sigmoidal dose-response (variable slope) equation available in GraphPad Prism (Equation 1 );
Competitive displacement data were then plotted with GraphPad Prism software and data were fit toEquation 1 to determine the IC50 value.
For fractional occupancy determination in kinase profiling experiments, the following equation (Equation 2 ) was used; where X = BRET in the presence of the test compound and energy transfer probe, Y = BRET in the presence of only energy transfer probe, and Z = BRET in the absence of the energy transfer probe and test compound. Predicted biochemical occupancy at the chosen drug dose for kinase profiling experiments was determined from the Kd value reported previously (Davis et al., 2011 (link)) using a variation of the Langmuir Isotherm (Hulme and Trevethick, 2010 (link)) (Equation 3 );
For all BRET data shown, no individual data points were omitted.
Competitive displacement data were then plotted with GraphPad Prism software and data were fit to
For fractional occupancy determination in kinase profiling experiments, the following equation (
For all BRET data shown, no individual data points were omitted.
Full text: Click here